Everything published about Thymosin Alpha-1: mechanism, research areas, results, regimens, risks, comparisons — plus the dated Vietnam price and ordering rules.
| Format | Price (index Nov 2, 2026) | Delivery |
|---|---|---|
| 10 mg | from 1 900 000 ₫ | Da Nang ~30 min · Vietnam 1–2 days |
Thymosin Alpha-1 is a 28-amino-acid peptide associated with immune signalling. Its synthetic form, thymalfasin, has been investigated in infections and other conditions involving altered immune responses.
An immune-signalling peptide with country- and indication-specific clinical use. Research focuses on the coordination of T-cell, dendritic-cell and other immune responses.
A well-studied immune-signalling peptide with a focused role in research on coordinated immune responses.
Clinical research spans chronic viral infections and adjunctive immune treatment. Results depend on the condition: a large sepsis trial did not show a clear reduction in 28-day mortality. Immune regulation remains the central research interest.
Immune-support research protocol: 1.6 mg subcutaneously, two to three times weekly. Duration: at least three months. Immune markers are reassessed after three months. Disease-specific clinical programmes use their own schedules.
Injection-site reactions and hypersensitivity can occur. Autoimmune conditions, transplantation and immunosuppressive treatment are particularly relevant to immune-modulating use.
Despite the shared word thymosin, these are different peptide families and research directions. Alpha-1 is studied mainly in immune regulation; beta-4-related compounds are discussed mainly in cell migration and repair biology.
from 1 900 000 ₫ for 10 mg (index Nov 2, 2026); final total confirmed in writing before payment.
No: research material, not a prescription drug; no medical claims.